Want to see SE:CARE full AI Analyst Report?
CARE Stock Chart & Stats
kr28.80
-kr0.20(-0.68%)
At close: 4:00 PM EDT
kr28.80
-kr0.20(-0.68%)
Day’s Range― - ―
52-Week Rangekr18.50 - kr30.80
Previous CloseN/A
Volume1.39K
Average Volume (3M)9.17K
Market Cap
kr656.81M
Enterprise Valuekr828.07
Total Cash (Recent Filing)kr40.30M
Total Debt (Recent Filing)kr206.70M
Price to Earnings (P/E)17.6
Beta0.45
Next Earnings
Oct 22, 2026EPS Estimate
0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.53
Shares Outstanding24,326,214
10 Day Avg. Volume7,786
30 Day Avg. Volume9,166
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.85
Price to Sales (P/S)0.68
P/FCF Ratio11.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.09
Revenue Forecast (FY)kr971.30M
Bulls Say, Bears Say
Bulls Say
Recurring Telecare Revenue ModelCareium combines device sales with ongoing service fees and active-user payments, creating an installed-base revenue stream. As connected users and long-term care relationships expand, recurring activity can improve revenue visibility and support durable customer retention.
Profitability Recovery And Renewed GrowthThe return to positive earnings after earlier loss-making years shows meaningful operational recovery. Renewed revenue growth alongside solid gross profitability provides a stronger foundation for reinvestment, customer support, and further scaling of Careium’s telecare platform.
Improving Balance Sheet And Positive Cash FlowModerate leverage and growing equity give Careium financial flexibility, while positive operating and free cash flow demonstrate that the business is generating funding internally. This combination can support resilience and investment without relying as heavily on additional borrowing.
Bears Say
Margin CompressionSales have resumed growth, but lower net and EBITDA margins indicate that recent expansion is not translating into earnings at the prior rate. Persistent cost pressure or unfavorable mix could limit profit growth and reduce the benefit of higher telecare volumes.
Weak Free-cash-flow ConversionPositive free cash flow is encouraging, yet conversion of reported earnings into discretionary cash remains limited. Working-capital or investment demands are absorbing a substantial portion of earnings, which may constrain debt reduction, reinvestment, or shareholder distributions.
Moderate Returns And Earnings ConsistencyCareium has returned to profitability, but the lower return on equity shows that capital is currently producing only moderate earnings. Sustaining improved returns will depend on consistent profitability and reversing the recent decline in operating efficiency.
CARE FAQ
What was Careium AB’s price range in the past 12 months?
Careium AB lowest stock price was kr18.50 and its highest was kr30.80 in the past 12 months.
What is Careium AB’s market cap?
Careium AB’s market cap is kr656.81M.
When is Careium AB’s upcoming earnings report date?
Careium AB’s upcoming earnings report date is Oct 22, 2026 which is in 25 days.
How were Careium AB’s earnings last quarter?
Careium AB released its earnings results on Jul 10, 2026. The company reported kr0.44 earnings per share for the quarter, beating the consensus estimate of kr0.23 by kr0.21.
Is Careium AB overvalued?
According to Wall Street analysts Careium AB’s price is currently Overvalued.
Does Careium AB pay dividends?
Careium AB does not currently pay dividends.
What is Careium AB’s EPS estimate?
Careium AB’s EPS estimate is 0.59.
How many shares outstanding does Careium AB have?
Careium AB has 24,326,214 shares outstanding.
What happened to Careium AB’s price movement after its last earnings report?
Careium AB reported an EPS of kr0.44 in its last earnings report, beating expectations of kr0.23. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Careium AB?
Currently, no hedge funds are holding shares in SE:CARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Careium AB
Careium AB (Publ), established in 1974 and headquartered in Malmö, Sweden, specializes in providing technologically advanced care solutions across numerous European nations, including Sweden, Norway, the United Kingdom, and the Netherlands. Their extensive product range covers a wide array of personal safety and environmental monitoring devices. This includes fundamental personal alert systems, such as fixed and mobile social alarms, alongside critical environmental sensors designed to detect smoke, heat, floods, carbon monoxide, and extreme temperatures. The company further enhances independent living through tools like fall detectors, automated pill dispensers, and specialized sensors for conditions such as epilepsy, as well as for beds (e.g., magic stick) and chairs. Additional assistive devices encompass mat, voice, chair, and bed alarms, alongside alternative control interfaces like blow switches, ping-pong switches, and ceiling-mounted pull cords. These are all integrated with secure communication services, ensuring efficient alarm response. Careium's offerings also feature advanced hardware, such as the mBox 9200, which functions as a versatile control unit, radio transmitter, range extender, and door alarm. They also provide the battery-operated Motion 9200 motion sensor and specific items like the Enzo bogus caller button. For individuals with disabilities or particular needs, the PikoButton offers a customizable control switch. To complete their service, the i-care online web platform provides a centralized system for managing and reviewing all connected alarm tools.
Technical Analysis
Medivir AB
―
Boule Diagnostics AB
―
New Nordic Healthbrands AB
―
Dedicare AB
―
Physitrack Limited
―